Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
Finerenone is developed for the treatment of diabetic kidney disease (adults) and chronic
kidney disease (children). The purpose of the proposed trial is to test the pharmacokinetics
of a novel liquid formulation for the treatment of children in comparison to the adult tablet
formulation.